Buprenorphine and Vivitrol perform equally well in head ‐to‐head study

The first head‐to‐head study comparing buprenorphine‐naloxone with extended‐release naltrexone in the United States has found both medications are equally successful at retaining patients 6 months later. The study, published online Nov. 14 in The Lancet, was led by senior author John Rotrosen, M.D., and colleagues at the NYU School of Medicine, and conducted in eight sites throughout the United States. The study was funded by the National Institute on Drug Abuse (NIDA).

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fcpu.30260

Source: The Brown University Child and Adolescent Psychopharmacology Update - November 28, 2017 Category: Psychiatry Tags: Substance use disorders Source Type: research